
    
      A Randomized, Double-blind, Placebo-controlled, Parallel-designed Study to Evaluate the
      Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Participants with Stable
      Coronary Heart Disease.
    
  